Rare EGFR mutations as oncogenic drivers

Presented By
Dr Alfredo Addeo (University Hospital of Geneva, Switzerland) and Dr Giulia Pasello (Veneto Institute of Oncology, Italy)
Conference
ELCC 2022

Expert
Nieuwe presenter, George Washington University School of Medicine, USA
Trial
Phase 3, ADvocate1; ADvocate2
Conference
AAD 2022

Darolutamide improves OS in mHSPC

Presented By
Dr Matthew Smith, Massachusetts General Hospital Cancer Center, MA, USA
Trial
Phase 3, ARASENS
Conference
ASCO GU 2022

Stopping DMT: when or if at all?

Presented By
Prof. Ilya Kister (NYU Grossman School of Medicine, NY, USA); Prof. Gavin Giovannoni (Queen Mary University of London, UK)
Conference
ECTRIMS 2021

Alcohol consumption during lockdown

Presented By
Ms Agnese Merlo & Ms Pauline A. Hendriksen, Utrecht Institute for Pharmaceutical Sciences
Conference
ECNP 2021

Updated results of SECOMBIT trial

Presented By
Prof. Paolo Ascierto, Istituto Nazionale Tumori "Fondazione Pascale", Italy
Trial
Phase 2, SECOMBIT
Conference
ESMO 2021